2010.[cited2013 June18], -
2010.Prevalence estimates of diabetes mellitus (DM), 2010 - MENA, -
SheraAS,JawadF,MaqsoodA, 2007.Prevalence of diabetes in Pakistan,Diabetes Res ClinPract 76 219 -22
FarrellGC,LarterCZ, 2006.Non-alcoholic fatty liver disease: From Steatosis to cirrhosis,Hepatology 43 S100 -12
ChalasaniN,YounossiZ,LavineJE,DiehlAM,BruntEM,CusiK, 2012.The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association,Hepatology 55 2005 -23
PreissD,SattarN., 2008.Non-alcoholic fatty liver disease: An overview of prevalence, diagnosis, pathogenesis and treatment considerations,ClinSci (Lond) 115 141 -50
TolmanKG,FonsecaV,TanMH,DalpiazA, 2004.Narrative review: Hepatobiliary disease in type 2 diabetes mellitus,Ann Intern Med 141 946 -56
GupteP,AmarapurkarD,AgalS,BaijalR,KulshresthaP,PramanikS, 2004.Non-alcoholic steatohepatitis in type 2 diabetes mellitus,J Gastroenterol Hepatol 19 854 -8
PrashanthM,GaneshHK,VimaMV,JohnM,BandgarT,JoshiSR, 2009.Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus,J Assoc Physicians India 57 205 -10
KalraS,VithalaniM,GulatiG,KulkarniCM,KadamY,PallivathukkalJ, 2013.Study of prevalence of non-alcoholic fatty liver disease (NAFLD) in Type 2 diabetes patients in India,J Assoc Physicians India 61 448 -53
TaseerIH,HussainL,SafdarS,MirbaharAM,AhmadI., 2009.Frequency of non-alcoholic fatty liver disease (NAFLD) & its biochemical derangements in Type-2 diabetic patients,Pak J Med Sci 25 817 -20
AnsariA,BilalN., 2005.Frequency of non-alcoholic steatohepatitis (NASH) in type 2 Diabetes Mellitus,Ann Pak Inst Med Sci 1 227 -9
2001.Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III),JAMA 285 2486 -
ClarkJM,Diehl IS, 2003.Non-alcoholic fatty liver disease: An underrecognized cause of cryptogenic cirrhosis,JAMA 289 3000 -4
CollantesR,OngJP,YounossiZM, 2004.Non-alcoholic fatty liver disease and the epidemic of obesity,Cleve Clin J Med 71 657 -64
ByronD,MinukG., 1996.Clinical hepatology: Profile of an urban, hospital-based practice,Hepatology 24 813 -5
JimbaS,NakagamiT,TakahashiM,WakamatsuT,HirotaY,IwamotoY,WasadaT., 2005.Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults,Diabet Med 22 1141 -5
SchaffnerF,ThalerH, 1986.Non-alcoholic fatty liver disease,Prog Liver Dis 8 283 -98
SilvermanJF,O'BrienKF,LongS., 1990.Liver pathology in morbid obese patients with and without diabetes,Am J Gastroenterol 85 1349 -55
BaconBR,FarahvashMJ,JanneyCG,Neuschwander-TetriBA, 1994.Non-alcoholic steatohepatitis-an expanded clinical entity,Gastroenterology 107 1103 -9
UygunA,KadayifciA,IsikAT, 2004.Metformin in the treatment of patients with non-alcoholic steatohepatitis,Aliment Pharmacol Ther 19 537 -44
ReinesHD,GoodmanZ,YounossiZM, 2005.Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients,Obes Surg 15 310 -5
BeymerC,KowdleyKV,LarsonA,EdmonsonP,DellingerEP,FlumDR, 2003.Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery,Arch Surg 138 1240 -4
AmarapurkarDN,AmarapurkarAD,PatelND,AgalS,BaigalR,GupteP, 2006.Non-alcoholic steatohepatitis (NASH) with diabetes: Predictors of liver fibrosis,Ann Hepatol 5 30 -3
MarchesiniG,BugianesiE,ForlaniG,CerrelliF,LenziM,ManiniR, 2003.Non-alcoholic fatty liver, steatohepatitis, and the metabolic syndrome,Hepatology 37 917 -23